Reliance Subsidiary Strand Life Sciences Gets Patent for Blood Test-Based Early Cancer Detection Technology
BENGALURU, July 7, 2026 (Udaipur Kiran) : Strand Life Sciences, a subsidiary of Reliance Industries, has received an Indian patent for a technology that can help detect cancer at an early stage and identify its possible source using only a blood sample. According to the company, the platform analyses cell-free DNA and uses genome sequencing, biological … Read more
